|
Symbol
|
PMWLTQ | Z093XZ | OCJRCH | IHTEFG | HZJEFG | RMBFAV | OOIRCH | RLOALV | Z09YGZ | PBURCH | RMA3QV | RMBRKV | ERORCH | PEIRCH | ABMUTQ | PJIRCH | AZFBIL | PRZRCH | Z0ARNZ | CQWBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible |
|
Underlying
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Lonza Group N / Tecan Group AG / Ypsomed Hldg. AG | Kühne & Nagel Intl. AG / Lonza Group N / Sandoz Group AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche GS / Sika AG | Kühne & Nagel Intl. AG / Lonza Group N / Sika AG | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Lonza Group N / VAT Group | Lonza Group N | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Lonza Group N / Novartis AG / Roche AG / Sandoz | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Companie Financière Richemont SA / Julius Baer Group / Lonza Group N | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis N / Roche GS / Straumann Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
09.02.2026 | 19.02.2026 | 08.04.2026 | 28.06.2029 | 02.11.2026 | 13.07.2026 | 15.01.2026 | 30.12.2025 | 27.08.2027 | 21.07.2026 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 11.11.2026 | 20.12.2029 | 16.06.2026 | 04.02.2026 | 24.02.2027 | 25.08.2026 | 13.03.2028 |
| Ratio | - | - | - | - | - | - | - | 0.09944 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Strike price
|
401.66 | 357.44 | 414.6035 | 310.18 | 364.182 | 401.70 | 326.43 | 497.20 | 179.883 | 367.64 | 28.08 | 197.80 | 100.685 | 191.17 | 346.32 | 44.0525 | 447.90 | 97.965 | 463.386 | 65.8989 |
| Max. yield p.a. | - | 640.33% | 39.77% | - | - | 63.81% | 14.18% | - | 13.96% | 7.75% | 7.55% | 28.06% | 5.65% | 4.58% | 13.12% | 8.22% | -0.08% | 5.55% | 6.58% | 7.22% |
| Bid | 96.05 | 48.220 | - | - | 86.64 | 77.10 | 99.47 | 99.70 | - | - | 97.60 | 91.90 | - | 99.58 | 77.28 | 97.68 | 101.11 | 97.73 | - | 94.94 |
| Ask | - | 49.120 | - | - | - | 77.90 | 100.27 | 100.30 | - | - | 98.40 | 92.70 | - | 100.38 | 78.06 | 98.48 | 101.92 | 98.53 | - | 95.74 |